Your browser doesn't support javascript.
loading
Oxaliplatin-related dysphagia: Mixed-methods study.
Kenny, Ciarán; Regan, Julie; Balding, Lucy; Higgins, Stephen; O'Leary, Norma; Kelleher, Fergal; McDermott, Ray; Armstrong, John; Mihai, Alina; Tiernan, Eoin; Westrup, Jennifer; Thirion, Pierre; Walsh, Declan.
Afiliação
  • Kenny C; Department of Clinical Speech and Language Studies, University of Dublin Trinity College, Dublin, Ireland ckenny9@tcd.ie.
  • Regan J; Department of Clinical Speech and Language Studies, University of Dublin Trinity College, Dublin, Ireland.
  • Balding L; Our Lady's Hospice and Care Services, Dublin, Ireland.
  • Higgins S; Our Lady's Hospice and Care Services, Dublin, Ireland.
  • O'Leary N; Our Lady's Hospice and Care Services, Dublin, Ireland.
  • Kelleher F; Tallaght University Hospital, Dublin, Ireland.
  • McDermott R; Tallaght University Hospital, Dublin, Ireland.
  • Armstrong J; Beacon Hospital, Sandyford, Ireland.
  • Mihai A; Beacon Hospital, Sandyford, Ireland.
  • Tiernan E; Beacon Hospital, Sandyford, Ireland.
  • Westrup J; Beacon Hospital, Sandyford, Ireland.
  • Thirion P; Beacon Hospital, Sandyford, Ireland.
  • Walsh D; Beacon Hospital, Sandyford, Ireland.
Article em En | MEDLINE | ID: mdl-38326014
ABSTRACT

OBJECTIVES:

To evaluate participant-reported atypical dysphagia symptoms and their association with oxaliplatin treatment.

METHODS:

This observational study recruited 73 adults with solid tumours outside the head, neck or upper gastrointestinal tract. All had dysphagia, were in hospital or hospice and were treated by Medical Oncology, Radiation Oncology or Palliative Care. Participants reported their experiences of swallowing difficulties by semistructured interview. Oral Health Assessment Tool was used to ensure swallow difficulties were not due to mucositis. Responses were transcribed and analysed by content analysis. Atypical difficulties were examined for association with oxaliplatin treatment by Fischer's Exact.

RESULTS:

Oxaliplatin treatment was associated with three unusual dysphagia symptoms problems with cold or hot bolus (p=0.01), pins and needles (p=0.001) and throat spasm (p=0.035). Carbonation was problematic for one participant. Chemotherapy commencement coincided with swallow problem onset for 67%. Dysphagia symptoms were unrelated to mucositis (p=0.165).

CONCLUSIONS:

Swallowing difficulties in oxaliplatin-treated patients are atypical and attributable to chemotherapy commencement. Previous research suggests that dysphagia is triggered by cold exposure, but hot and carbonated boluses also caused problems here. Dysphagia symptoms and triggers should be studied more fully to help patients safely enjoy their meals and prevent food avoidance, which could exacerbate malnutrition.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Qualitative_research Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Qualitative_research Idioma: En Ano de publicação: 2024 Tipo de documento: Article